Isradipine

Generic name: Pronounced as (iz ra' di peen)
Brand names
  • DynaCirc®
  • DynaCirc® CR
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 11/15/2017

Isradipine is used to treat high blood pressure. Isradipine is in a class of medications called calcium channel blockers. It works by relaxing the blood vessels so your heart does not have to pump as hard.

High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Isradipine comes as a capsule to take by mouth. The capsule is usually taken two times a day. To help you remember to take isradipine, take it around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take isradipine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Isradipine controls high blood pressure but does not cure it. Continue to take isradipine even if you feel well. Do not stop taking isradipine without talking to your doctor.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking isradipine,

  • tell your doctor and pharmacist if you are allergic to isradipine, any other medications, or any ingredients in isradipine capsules. Ask your pharmacist for a list of the ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: cimetidine (Tagamet), fentanyl (Duragesic), heart and blood pressure medications such as beta-blockers and diuretics ('water pills'), ranitidine (Zantac), and rifampin (Rifadin, Rimactane).

  • tell your doctor if you have or have ever had heart, liver, or kidney disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking isradipine, call your doctor.

  • if you are having surgery, including dental surgery, tell your doctor or dentist that you are taking isradipine.

Talk to your doctor about drinking grapefruit juice or eating grapefruit while taking isradipine.

Talk to your doctor before using salt substitutes containing potassium. If your doctor prescribes a low-salt or low-sodium diet, follow these directions carefully.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Isradipine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • dizziness or lightheadedness

    • flushing

    • fast heartbeat

    • excessive tiredness

    • upset stomach

    • vomiting

    • diarrhea

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately or get emergency medical treatment:

    • chest pain

    • swelling of the face, eyes, lips, tongue, arms, or legs

    • difficulty breathing or swallowing

    • fainting

    • rash

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor and the laboratory. Your blood pressure should be checked regularly to determine your response to isradipine.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Moxifloxacin.
Repaglinide Repaglinide Isradipine may decrease the excretion rate of Repaglinide which could result in a higher serum level.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin glargine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Isradipine.
Dolasetron Dolasetron The risk or severity of QTc prolongation can be increased when Isradipine is combined with Dolasetron.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Isradipine.
Anagrelide Anagrelide The risk or severity of QTc prolongation can be increased when Isradipine is combined with Anagrelide.
Bisacodyl Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Isradipine.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Candesartan.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Isradipine.
Clopidogrel Clopidogrel The therapeutic efficacy of Clopidogrel can be decreased when used in combination with Isradipine.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The risk or severity of QTc prolongation and hypotension can be increased when Erythromycin is combined with Isradipine.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Isradipine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Isradipine.
Guanfacine Guanfacine Isradipine may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Gluconate Magnesium Gluconate The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium gluconate.
Magnesium Hydroxide Magnesium Hydroxide The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium hydroxide.
Magnesium Oxide Magnesium Oxide The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium oxide.
Methylergonovine Methylergonovine Methylergometrine may decrease the antihypertensive activities of Isradipine.
Miglitol Miglitol The risk or severity of hypoglycemia can be increased when Isradipine is combined with Miglitol.
Mycophenolate Mycophenolate Isradipine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan Naratriptan may decrease the antihypertensive activities of Isradipine.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Isradipine.
Penbutolol Penbutolol The risk or severity of bradycardia can be increased when Isradipine is combined with Acebutolol.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Isradipine.
Potassium Potassium Potassium may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Isradipine may decrease the excretion rate of Prednisone which could result in a higher serum level.
Psyllium Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Isradipine.
Ranitidine Ranitidine Isradipine may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine Reserpine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Rizatriptan Rizatriptan Isradipine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Isradipine which could result in a higher serum level.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Isradipine.
Tizanidine Tizanidine The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Isradipine.
Zolmitriptan Zolmitriptan Zolmitriptan may decrease the antihypertensive activities of Isradipine.
Ampicillin Injection Ampicillin Injection Isradipine may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Isradipine which could result in a higher serum level.
Famotidine Injection Famotidine Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Famotidine.
Fluconazole Injection Fluconazole Injection The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Isradipine.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Isradipine which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Isradipine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Isradipine.
Metoclopramide Injection Metoclopramide Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Metoclopramide.
Metronidazole Injection Metronidazole Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Metronidazole.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Isradipine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Isradipine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Isradipine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine Amphetamine may increase the hypotensive activities of Isradipine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cyclosporine Cyclosporine The metabolism of Cyclosporine can be decreased when combined with Isradipine.
Ondansetron Ondansetron The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Isradipine is combined with Enoxaparin.
Granisetron Granisetron The risk or severity of QTc prolongation can be increased when Isradipine is combined with Granisetron.
Torsemide Torsemide Torasemide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Olanzapine.
Dofetilide Dofetilide Isradipine may increase the arrhythmogenic activities of Dofetilide.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Eprosartan.
Hydroxychloroquine Hydroxychloroquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Hydroxychloroquine.
Meloxicam Meloxicam The therapeutic efficacy of Isradipine can be decreased when used in combination with Meloxicam.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Isradipine which could result in a higher serum level.
Telmisartan Telmisartan Isradipine may decrease the excretion rate of Telmisartan which could result in a higher serum level.
Temozolomide Temozolomide Isradipine may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Isradipine may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Desloratadine Desloratadine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Desloratadine.
Linezolid Linezolid Linezolid may increase the hypotensive activities of Isradipine.
Rivastigmine Rivastigmine Isradipine may increase the bradycardic activities of Rivastigmine.
Trimipramine Trimipramine The risk or severity of QTc prolongation can be increased when Trimipramine is combined with Isradipine.
Perindopril Perindopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Perindopril.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The therapeutic efficacy of Isradipine can be decreased when used in combination with Choline magnesium trisalicylate.
Sirolimus Sirolimus Isradipine may increase the immunosuppressive activities of Sirolimus.
Dutasteride Dutasteride Dutasteride may decrease the antihypertensive activities of Isradipine.
Epinephrine Injection Epinephrine Injection Epinephrine may decrease the antihypertensive activities of Isradipine.
Eplerenone Eplerenone The metabolism of Eplerenone can be decreased when combined with Isradipine.
Escitalopram Escitalopram The risk or severity of QTc prolongation can be increased when Isradipine is combined with Escitalopram.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Isradipine which could result in a higher serum level.
Zonisamide Zonisamide Isradipine may increase the arrhythmogenic activities of Zonisamide.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Isradipine.
Atomoxetine Atomoxetine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Atomoxetine.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may decrease the antihypertensive activities of Isradipine.
Ezetimibe Ezetimibe Isradipine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.
Atazanavir Atazanavir Isradipine may decrease the excretion rate of Atazanavir which could result in a higher serum level.
Almotriptan Almotriptan Isradipine may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eletriptan Eletriptan Eletriptan may decrease the antihypertensive activities of Isradipine.
Mefloquine Mefloquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Mefloquine.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Isradipine.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Isradipine.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Isradipine.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Isradipine.
Emtricitabine Emtricitabine Isradipine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Isradipine may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The therapeutic efficacy of Tegaserod can be decreased when used in combination with Isradipine.
Tadalafil Tadalafil Isradipine may increase the antihypertensive activities of Tadalafil.
Frovatriptan Frovatriptan Frovatriptan may decrease the antihypertensive activities of Isradipine.
Gemifloxacin Gemifloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Gemifloxacin.
Progesterone Progesterone Progesterone may decrease the excretion rate of Isradipine which could result in a higher serum level.
Apomorphine Injection Apomorphine Injection The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Isradipine.
Protriptyline Protriptyline The risk or severity of QTc prolongation can be increased when Isradipine is combined with Protriptyline.
Duloxetine Duloxetine The risk or severity of orthostatic hypotension and syncope can be increased when Isradipine is combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Isradipine.
Tinidazole Tinidazole Isradipine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan Bosentan may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cefditoren Cefditoren Isradipine may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Isradipine.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Isradipine.
Ganciclovir Ganciclovir Isradipine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin aspart.
Ribavirin Ribavirin Isradipine may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Isradipine.
Valganciclovir Valganciclovir Isradipine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the hypotensive activities of Isradipine.
Pramlintide Injection Pramlintide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Pramlintide.
Exenatide Injection Exenatide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Exenatide.
Ibandronate Ibandronate The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ibandronate.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the hypotensive activities of Isradipine.
Ramelteon Ramelteon Isradipine may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Isradipine.
Pregabalin Pregabalin Pregabalin may increase the arrhythmogenic activities of Isradipine.
Phenylephrine Phenylephrine The risk or severity of hypertension can be decreased when Phenylephrine is combined with Isradipine.
Tipranavir Tipranavir Tipranavir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Felbamate Felbamate The risk or severity of QTc prolongation can be increased when Isradipine is combined with Felbamate.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin detemir.
Ranolazine Ranolazine The metabolism of Ranolazine can be decreased when combined with Isradipine.
Rasagiline Rasagiline Rasagiline may increase the hypotensive activities of Isradipine.
Imatinib Imatinib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Imatinib.
Sitagliptin Sitagliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Sitagliptin.
Varenicline Varenicline Isradipine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Albuterol Albuterol The risk or severity of QTc prolongation can be increased when Isradipine is combined with Salbutamol.
Paliperidone Paliperidone The risk or severity of QTc prolongation can be increased when Isradipine is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Isradipine can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection Isradipine may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin glulisine.
Lubiprostone Lubiprostone Isradipine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Oxaliplatin.
Posaconazole Posaconazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Posaconazole.
Primaquine Primaquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Primaquine.
Rituximab Injection Rituximab Injection Isradipine may increase the hypotensive activities of Rituximab.
Aliskiren Aliskiren The risk or severity of hyperkalemia can be increased when Isradipine is combined with Aliskiren.
Darunavir Darunavir The serum concentration of Darunavir can be increased when it is combined with Isradipine.
Pemetrexed Injection Pemetrexed Injection Isradipine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate The risk or severity of QTc prolongation can be increased when Isradipine is combined with Dimenhydrinate.
Lisdexamfetamine Lisdexamfetamine Lisdexamfetamine may decrease the antihypertensive activities of Isradipine.
Nabilone Nabilone The risk or severity of adverse effects can be increased when Nabilone is combined with Isradipine.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Isradipine.
Vorinostat Vorinostat The risk or severity of QTc prolongation can be increased when Isradipine is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Sorafenib can be decreased when combined with Isradipine.
Sunitinib Sunitinib The metabolism of Sunitinib can be decreased when combined with Isradipine.
Lapatinib Lapatinib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Lapatinib.
Levocetirizine Levocetirizine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Levocetirizine.
Pegaptanib Injection Pegaptanib Injection Isradipine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Isradipine.
Mexiletine Mexiletine Isradipine may increase the arrhythmogenic activities of Mexiletine.
Azacitidine Injection Azacitidine Injection Isradipine may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Isradipine.
Temsirolimus Temsirolimus The metabolism of Temsirolimus can be decreased when combined with Isradipine.
Lenalidomide Lenalidomide Isradipine may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Isradipine.
Toremifene Toremifene The risk or severity of QTc prolongation can be increased when Isradipine is combined with Toremifene.
Budesonide Budesonide Isradipine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Doripenem Injection Doripenem Injection Isradipine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Arsenic trioxide.
Desvenlafaxine Desvenlafaxine Isradipine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Isradipine which could result in a higher serum level.
Nebivolol Nebivolol The risk or severity of bradycardia can be increased when Isradipine is combined with Nebivolol.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Isradipine.
Flecainide Flecainide Isradipine may increase the arrhythmogenic activities of Flecainide.
Certolizumab Injection Certolizumab Injection Isradipine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Ixabepilone Injection Ixabepilone Injection The metabolism of Ixabepilone can be decreased when combined with Isradipine.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be decreased when combined with Isradipine.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Isradipine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide The metabolism of Rufinamide can be decreased when combined with Isradipine.
Silodosin Silodosin The risk or severity of hypotension can be increased when Silodosin is combined with Isradipine.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Isradipine.
Dexrazoxane Injection Dexrazoxane Injection Isradipine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Milnacipran Milnacipran Isradipine may decrease the excretion rate of Milnacipran which could result in a higher serum level.
Plerixafor Injection Plerixafor Injection Isradipine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate Isradipine may increase the hyperkalemic activities of Sodium phosphate, monobasic.
Fesoterodine Fesoterodine Isradipine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Degarelix Injection Degarelix Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Degarelix.
Betaxolol Betaxolol The risk or severity of bradycardia can be increased when Isradipine is combined with Betaxolol.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Isradipine.
Prasugrel Prasugrel Isradipine may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Isradipine.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Isradipine.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Tolvaptan can be decreased when combined with Isradipine.
Dronedarone Dronedarone Dronedarone may increase the arrhythmogenic activities of Isradipine.
Pralatrexate Injection Pralatrexate Injection Isradipine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Isradipine may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Saxagliptin.
Telavancin Injection Telavancin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Telavancin.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be decreased when combined with Isradipine.
Topotecan Topotecan Isradipine may decrease the excretion rate of Topotecan which could result in a higher serum level.
Pazopanib Pazopanib The metabolism of Pazopanib can be decreased when combined with Isradipine.
Asenapine Asenapine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Asenapine.
Pitavastatin Pitavastatin Isradipine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Isradipine.
Liraglutide Injection Liraglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Liraglutide.
Dalfampridine Dalfampridine Isradipine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Fingolimod Fingolimod Isradipine may increase the bradycardic activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Cabazitaxel can be decreased when combined with Isradipine.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Isradipine which could result in a higher serum level.
Lurasidone Lurasidone The metabolism of Lurasidone can be decreased when combined with Isradipine.
Acetaminophen Injection Acetaminophen Injection Isradipine may decrease the excretion rate of Acetaminophen which could result in a higher serum level.
Vilazodone Vilazodone Vilazodone may decrease the antihypertensive activities of Isradipine.
Ipilimumab Injection Ipilimumab Injection Isradipine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Terbutaline.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Azilsartan medoxomil.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Isradipine.
Roflumilast Roflumilast The metabolism of Roflumilast can be decreased when combined with Isradipine.
Linagliptin Linagliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Linagliptin.
Rilpivirine Rilpivirine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Rilpivirine.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Isradipine.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be decreased when combined with Isradipine.
Triptorelin Injection Triptorelin Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Triptorelin.
Rivaroxaban Rivaroxaban Isradipine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Isradipine.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the bradycardic activities of Isradipine.
Vandetanib Vandetanib The metabolism of Vandetanib can be decreased when combined with Isradipine.
Clobazam Clobazam Isradipine may decrease the excretion rate of Clobazam which could result in a higher serum level.
Vemurafenib Vemurafenib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Vemurafenib.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be decreased when combined with Isradipine.
Deferiprone Deferiprone Isradipine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Isradipine.
Crizotinib Crizotinib The metabolism of Crizotinib can be decreased when combined with Isradipine.
Cabergoline Cabergoline The metabolism of Isradipine can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection Isradipine may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan Isradipine may increase the hypotensive activities of Ambrisentan.
Fondaparinux Injection Fondaparinux Injection Isradipine may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Iloprost Iloprost Iloprost may increase the hypotensive activities of Isradipine.
Enzalutamide Enzalutamide Isradipine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Isradipine.
Regorafenib Regorafenib The metabolism of Regorafenib can be decreased when combined with Isradipine.
Bosutinib Bosutinib The metabolism of Bosutinib can be decreased when combined with Isradipine.
Linaclotide Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Isradipine.
Lorcaserin Lorcaserin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Mecasermin.
Teduglutide Injection Teduglutide Injection Isradipine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Bedaquiline Bedaquiline The risk or severity of QTc prolongation can be increased when Isradipine is combined with Bedaquiline.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Isradipine.
Alogliptin Alogliptin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Alogliptin.
Ponatinib Ponatinib The metabolism of Ponatinib can be decreased when combined with Isradipine.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Isradipine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be decreased when combined with Isradipine.
Canagliflozin Canagliflozin Isradipine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be decreased when combined with Isradipine.
Trametinib Trametinib Isradipine may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Isradipine may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.
Ertapenem Injection Ertapenem Injection Isradipine may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Isradipine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Isradipine.
Lomitapide Lomitapide The metabolism of Lomitapide can be decreased when combined with Isradipine.
Avanafil Avanafil The metabolism of Avanafil can be decreased when combined with Isradipine.
Ketorolac Injection Ketorolac Injection The therapeutic efficacy of Isradipine can be decreased when used in combination with Ketorolac.
Obinutuzumab Injection Obinutuzumab Injection Isradipine may increase the hypotensive activities of Obinutuzumab.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Sofosbuvir Sofosbuvir Isradipine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Isradipine may increase the excretion rate of Dapagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast Isradipine may decrease the excretion rate of Apremilast which could result in a higher serum level.
Droxidopa Droxidopa Isradipine may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib Isradipine may increase the bradycardic activities of Ceritinib.
Albiglutide Injection Albiglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Albiglutide.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Isradipine.
Testosterone Injection Testosterone Injection Isradipine may decrease the excretion rate of Testosterone which could result in a higher serum level.
Empagliflozin Empagliflozin The risk or severity of hypoglycemia can be increased when Empagliflozin is combined with Isradipine.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Isradipine.
Suvorexant Suvorexant The metabolism of Suvorexant can be decreased when combined with Isradipine.
Dulaglutide Injection Dulaglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Dulaglutide.
Edoxaban Edoxaban Isradipine may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Isradipine.
Methamphetamine Methamphetamine Isradipine may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Isradipine.
Riociguat Riociguat Isradipine may increase the hypotensive activities of Riociguat.
Lanreotide Injection Lanreotide Injection Isradipine may increase the bradycardic activities of Lanreotide.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Isradipine.
Risperidone Injection Risperidone Injection Isradipine may increase the hypotensive activities of Risperidone.
Palbociclib Palbociclib The metabolism of Palbociclib can be decreased when combined with Isradipine.
Insulin Human Inhalation Insulin Human Inhalation The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin human.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Isradipine which could result in a higher serum level.
Naloxegol Naloxegol The metabolism of Naloxegol can be decreased when combined with Isradipine.
Panobinostat Panobinostat The metabolism of Panobinostat can be decreased when combined with Isradipine.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Dinutuximab is combined with Isradipine.
Haloperidol Injection Haloperidol Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Haloperidol.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Ivabradine Ivabradine The metabolism of Ivabradine can be decreased when combined with Isradipine.
Amiloride Amiloride Isradipine may increase the excretion rate of Amiloride which could result in a lower serum level and potentially a reduction in efficacy.
Isavuconazonium Injection Isavuconazonium Injection The therapeutic efficacy of Isavuconazonium can be increased when used in combination with Isradipine.
Macitentan Macitentan Isradipine may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Isradipine.
Flibanserin Flibanserin The metabolism of Flibanserin can be decreased when combined with Isradipine.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Isradipine.
Ziprasidone Injection Ziprasidone Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ziprasidone.
Cariprazine Cariprazine Cariprazine may decrease the antihypertensive activities of Isradipine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Isradipine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Isradipine.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be decreased when combined with Isradipine.
Osimertinib Osimertinib The metabolism of Osimertinib can be decreased when combined with Isradipine.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Isradipine.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Isradipine.
Lesinurad Lesinurad Isradipine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Isradipine may decrease the nephrotoxic activities of Amphotericin B.
Dexamethasone Injection Dexamethasone Injection Dexamethasone may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Brivaracetam Injection Brivaracetam Injection Isradipine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The metabolism of Venetoclax can be decreased when combined with Isradipine.
Midodrine Midodrine Midodrine may increase the bradycardic activities of Isradipine.
Selexipag Selexipag Isradipine may increase the hypotensive activities of Selexipag.
Diphenhydramine Injection Diphenhydramine Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Diphenhydramine.
Furosemide Injection Furosemide Injection Isradipine may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy.
Lixisenatide Injection Lixisenatide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Lixisenatide.
Ribociclib Ribociclib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ribociclib.
Brigatinib Brigatinib The metabolism of Brigatinib can be decreased when combined with Isradipine.
Doxepin (Insomnia) Doxepin (Insomnia) The risk or severity of QTc prolongation can be increased when Doxepin is combined with Isradipine.
Plecanatide Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Isradipine.
Deutetrabenazine Deutetrabenazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Deutetrabenazine.
Valbenazine Valbenazine Isradipine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The serum concentration of Isradipine can be increased when it is combined with Deflazacort.
Safinamide Safinamide Safinamide may increase the hypotensive activities of Isradipine.
Naldemedine Naldemedine Isradipine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Midostaurin Midostaurin The metabolism of Midostaurin can be decreased when combined with Isradipine.
Neratinib Neratinib The metabolism of Neratinib can be decreased when combined with Isradipine.
Enasidenib Enasidenib The metabolism of Enasidenib can be decreased when combined with Isradipine.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be decreased when combined with Isradipine.
Benznidazole Benznidazole Isradipine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Isradipine.
Delafloxacin Delafloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Delafloxacin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Isradipine.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Isradipine.
Letermovir Letermovir Letermovir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Semaglutide Injection Semaglutide Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Semaglutide.
Tetrabenazine Tetrabenazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Tetrabenazine.
Ertugliflozin Ertugliflozin Isradipine may increase the excretion rate of Ertugliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Apalutamide Apalutamide Isradipine may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Fostamatinib Fostamatinib Fostamatinib may increase the antihypertensive activities of Isradipine.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Isradipine.
Lofexidine Lofexidine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Lofexidine.
Plazomicin Injection Plazomicin Injection Isradipine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Isradipine.
Encorafenib Encorafenib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Encorafenib.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be decreased when combined with Isradipine.
Cannabidiol Cannabidiol Cannabidiol may decrease the antihypertensive activities of Isradipine.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Isradipine.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Isradipine.
Stiripentol Stiripentol Isradipine may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Gilteritinib Gilteritinib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Gilteritinib.
Glasdegib Glasdegib The risk or severity of QTc prolongation can be increased when Isradipine is combined with Glasdegib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Isradipine.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Isradipine.
Magnesium Citrate Magnesium Citrate The risk or severity of hypotension can be increased when Isradipine is combined with Magnesium citrate.
Siponimod Siponimod The risk or severity of adverse effects can be increased when Isradipine is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be decreased when combined with Isradipine.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Isradipine.
Solriamfetol Solriamfetol Isradipine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Triclabendazole Triclabendazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Triclabendazole.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Isradipine.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Isradipine.
Pitolisant Pitolisant The serum concentration of Isradipine can be decreased when it is combined with Pitolisant.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Isradipine.
Lefamulin Lefamulin Isradipine may increase the QTc-prolonging activities of Lefamulin.
Phenytoin Injection Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Isradipine.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Isradipine.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Isradipine.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Isradipine.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Isradipine.
Lasmiditan Lasmiditan Lasmiditan may increase the bradycardic activities of Isradipine.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Isradipine.
Calcium Acetate Calcium Acetate The therapeutic efficacy of Isradipine can be decreased when used in combination with Calcium acetate.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Isradipine.
Cenobamate Cenobamate The serum concentration of Isradipine can be decreased when it is combined with Cenobamate.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Isradipine.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Isradipine.
Rimegepant Rimegepant The metabolism of Rimegepant can be decreased when combined with Isradipine.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Isradipine.
Selpercatinib Selpercatinib Selpercatinib may decrease the antihypertensive activities of Isradipine.
Fostemsavir Fostemsavir The risk or severity of QTc prolongation can be increased when Isradipine is combined with Fostemsavir.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Isradipine.
Octreotide Octreotide The serum concentration of the active metabolites of Isradipine can be increased when Isradipine is used in combination with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Isradipine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Isradipine which could result in a higher serum level.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Isradipine can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection Naxitamab may decrease the antihypertensive activities of Isradipine.
Relugolix Relugolix The risk or severity of QTc prolongation can be increased when Isradipine is combined with Relugolix.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Isradipine may increase the excretion rate of Drospirenone which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Isradipine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Theophylline Theophylline The metabolism of Isradipine can be decreased when combined with Theophylline.
Fenoprofen Fenoprofen The therapeutic efficacy of Isradipine can be decreased when used in combination with Fenoprofen.
Indomethacin Indomethacin Isradipine may decrease the excretion rate of Indomethacin which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid The therapeutic efficacy of Isradipine can be decreased when used in combination with Mefenamic acid.
Naproxen Naproxen The therapeutic efficacy of Isradipine can be decreased when used in combination with Naproxen.
Tolmetin Tolmetin The therapeutic efficacy of Isradipine can be decreased when used in combination with Tolmetin.
Sulindac Sulindac The therapeutic efficacy of Isradipine can be decreased when used in combination with Sulindac.
Trazodone Trazodone The risk or severity of QTc prolongation can be increased when Trazodone is combined with Isradipine.
Isotretinoin Isotretinoin Isradipine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Isradipine may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine Floxuridine Isradipine may decrease the excretion rate of Floxuridine which could result in a higher serum level.
Phenobarbital Phenobarbital Phenobarbital may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Metaxalone Metaxalone Isradipine may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The metabolism of Isradipine can be decreased when combined with Methotrexate.
Primidone Primidone The metabolism of Isradipine can be increased when combined with Primidone.
Methsuximide Methsuximide Isradipine may increase the arrhythmogenic activities of Methsuximide.
Diethylpropion Diethylpropion Diethylpropion may decrease the antihypertensive activities of Isradipine.
Chlorpromazine Chlorpromazine Chlorpromazine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Diazepam Diazepam Isradipine may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Isradipine may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Isradipine may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Isradipine may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam The metabolism of Isradipine can be decreased when combined with Lorazepam.
Phenoxybenzamine Phenoxybenzamine The risk or severity of hypotension can be increased when Phenoxybenzamine is combined with Isradipine.
Carmustine Carmustine Carmustine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Amantadine Amantadine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Amantadine.
Codeine Codeine Isradipine may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of hypotension can be increased when Bromocriptine is combined with Isradipine.
Metaproterenol Metaproterenol Orciprenaline may decrease the antihypertensive activities of Isradipine.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the hypotensive activities of Isradipine.
Phenelzine Phenelzine Phenelzine may increase the hypotensive activities of Isradipine.
Procarbazine Procarbazine Procarbazine may increase the hypotensive activities of Isradipine.
Ergoloid Mesylates Ergoloid Mesylates Ergoloid mesylate may decrease the antihypertensive activities of Isradipine.
Tetracycline Tetracycline Isradipine may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Prochlorperazine Prochlorperazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Prochlorperazine.
Thioridazine Thioridazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Thioridazine.
Trifluoperazine Trifluoperazine The risk or severity of hypotension can be increased when Trifluoperazine is combined with Isradipine.
Bleomycin Bleomycin Isradipine may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Sulfadiazine Sulfadiazine The risk or severity of hypoglycemia can be increased when Isradipine is combined with Sulfadiazine.
Methadone Methadone The risk or severity of QTc prolongation can be increased when Isradipine is combined with Methadone.
Benztropine Benztropine The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Isradipine.
Maprotiline Maprotiline The risk or severity of QTc prolongation can be increased when Isradipine is combined with Maprotiline.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Isradipine which could result in a higher serum level.
Orphenadrine Orphenadrine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Orphenadrine.
Azathioprine Azathioprine Isradipine may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Isradipine.
Methylphenidate Methylphenidate Methylphenidate may decrease the antihypertensive activities of Isradipine.
Amoxapine Amoxapine The risk or severity of hypotension can be increased when Amoxapine is combined with Isradipine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Doxorubicin Doxorubicin The metabolism of Doxorubicin can be decreased when combined with Isradipine.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Isradipine.
Methyldopa Methyldopa Isradipine may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine Clonidine may increase the atrioventricular blocking (AV block) activities of Isradipine.
Prazosin Prazosin The risk or severity of hypotension can be increased when Prazosin is combined with Isradipine.
Hydralazine Hydralazine Isradipine may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine The serum concentration of Isradipine can be increased when it is combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Isradipine.
Clonazepam Clonazepam Isradipine may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide Isradipine may increase the arrhythmogenic activities of Loperamide.
Promethazine Promethazine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Promethazine.
Meclofenamate Meclofenamate The therapeutic efficacy of Isradipine can be decreased when used in combination with Meclofenamic acid.
Daunorubicin Daunorubicin Isradipine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Isradipine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Isradipine may increase the arrhythmogenic activities of Digoxin.
Chloroquine Chloroquine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Chloroquine.
Quinine Quinine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Quinine.
Ethosuximide Ethosuximide Isradipine may increase the arrhythmogenic activities of Ethosuximide.
Triamterene Triamterene Isradipine may decrease the excretion rate of Triamterene which could result in a higher serum level.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Isradipine.
Sulfinpyrazone Sulfinpyrazone Isradipine may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be increased when used in combination with Isradipine.
Chlorthalidone Chlorthalidone Isradipine may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Isradipine may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the vasodilatory activities of Isradipine.
Secobarbital Secobarbital The metabolism of Isradipine can be increased when combined with Secobarbital.
Desipramine Desipramine The risk or severity of QTc prolongation can be increased when Desipramine is combined with Isradipine.
Amitriptyline Amitriptyline The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Isradipine.
Imipramine Imipramine The risk or severity of QTc prolongation can be increased when Imipramine is combined with Isradipine.
Probenecid Probenecid Isradipine may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine Isradipine may increase the arrhythmogenic activities of Quinidine.
Procainamide Procainamide Isradipine may increase the arrhythmogenic activities of Procainamide.
Isoniazid Isoniazid Isradipine may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Isradipine may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Rifampin Rifampin Rifampicin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Disopyramide Disopyramide Isradipine may increase the arrhythmogenic activities of Disopyramide.
Valproic Acid Valproic Acid The risk or severity of QTc prolongation can be increased when Isradipine is combined with Valproic acid.
Tamoxifen Tamoxifen The metabolism of Isradipine can be decreased when combined with Tamoxifen.
Butabarbital Butabarbital Butabarbital may increase the hypotensive activities of Isradipine.
Liothyronine Liothyronine Isradipine may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole Isradipine may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorpropamide Chlorpropamide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Chlorpropamide.
Tolbutamide Tolbutamide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Tolbutamide.
Tolazamide Tolazamide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Tolazamide.
Baclofen Baclofen The risk or severity of adverse effects can be increased when Baclofen is combined with Isradipine.
Doxylamine Doxylamine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Doxylamine.
Cyproheptadine Cyproheptadine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Cyproheptadine.
Clemastine Clemastine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Clemastine.
Chlorpheniramine Chlorpheniramine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Chlorpheniramine.
Brompheniramine Brompheniramine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Dexbrompheniramine.
Ethambutol Ethambutol Isradipine may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Isradipine can be increased when used in combination with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Isradipine can be increased when used in combination with Hydrochlorothiazide.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Dantrolene is combined with Isradipine.
Chlorzoxazone Chlorzoxazone Isradipine may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Isradipine which could result in a higher serum level.
Disulfiram Disulfiram The risk or severity of QTc prolongation can be increased when Isradipine is combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The risk or severity of bradycardia can be increased when Isradipine is combined with Propranolol.
Minoxidil Minoxidil Isradipine may increase the hypotensive activities of Minoxidil.
Pseudoephedrine Pseudoephedrine Pseudoephedrine may decrease the antihypertensive activities of Isradipine.
Nortriptyline Nortriptyline The metabolism of Isradipine can be decreased when combined with Nortriptyline.
Spironolactone Spironolactone Isradipine may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Isradipine may decrease the nephrotoxic activities of Amphotericin B.
Phytonadione Phytonadione Isradipine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Nadolol Nadolol The risk or severity of bradycardia can be increased when Isradipine is combined with Nadolol.
Allopurinol Allopurinol Isradipine may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Oxytocin Injection Oxytocin Injection The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Isradipine.
Flavoxate Flavoxate Isradipine may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Papaverine Papaverine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Papaverine.
Fluorouracil Injection Fluorouracil Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Fluorouracil.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Isradipine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Dacarbazine Dacarbazine Isradipine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Isradipine which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Isradipine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Ketoconazole Ketoconazole Ketoconazole may decrease the excretion rate of Isradipine which could result in a higher serum level.
Pyrantel Pyrantel Isradipine may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Thiotepa Injection Thiotepa Injection The metabolism of Thiotepa can be decreased when combined with Isradipine.
Vincristine Injection Vincristine Injection The metabolism of Vincristine can be decreased when combined with Isradipine.
Captopril Captopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Captopril.
Dipyridamole Dipyridamole Dipyridamole may decrease the excretion rate of Isradipine which could result in a higher serum level.
Isoxsuprine Isoxsuprine Isoxsuprine may decrease the antihypertensive activities of Isradipine.
Vinblastine Vinblastine The metabolism of Isradipine can be decreased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Isradipine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Isradipine which could result in a higher serum level.
Metoprolol Metoprolol The risk or severity of bradycardia can be increased when Isradipine is combined with Metoprolol.
Hydroxyzine Hydroxyzine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Hydroxyzine.
Thiothixene Thiothixene The risk or severity of QTc prolongation can be increased when Isradipine is combined with Thiothixene.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Isradipine which could result in a higher serum level.
Salsalate Salsalate The therapeutic efficacy of Isradipine can be decreased when used in combination with Salsalate.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Isradipine.
Temazepam Temazepam Temazepam may decrease the excretion rate of Isradipine which could result in a higher serum level.
Triazolam Triazolam Isradipine may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Isradipine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hyoscyamine Hyoscyamine Isradipine may increase the arrhythmogenic activities of Hyoscyamine.
Propantheline Propantheline Isradipine may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim The risk or severity of hyperkalemia can be increased when Isradipine is combined with Trimethoprim.
Diltiazem Diltiazem Isradipine may increase the arrhythmogenic activities of Diltiazem.
Nifedipine Nifedipine Isradipine may increase the arrhythmogenic activities of Nifedipine.
Timolol Timolol The risk or severity of adverse effects can be increased when Isradipine is combined with Timolol.
Verapamil Verapamil Verapamil may increase the arrhythmogenic activities of Isradipine.
Atenolol Atenolol The risk or severity of bradycardia can be increased when Isradipine is combined with Atenolol.
Pindolol Pindolol The risk or severity of bradycardia can be increased when Isradipine is combined with Pindolol.
Cisplatin Injection Cisplatin Injection Isradipine may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Isradipine which could result in a higher serum level.
Piroxicam Piroxicam The therapeutic efficacy of Isradipine can be decreased when used in combination with Piroxicam.
Bumetanide Bumetanide Isradipine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Etoposide Etoposide The metabolism of Etoposide can be decreased when combined with Isradipine.
Glyburide Glyburide Glyburide may decrease the excretion rate of Isradipine which could result in a higher serum level.
Glipizide Glipizide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Glipizide.
Indapamide Indapamide The therapeutic efficacy of Indapamide can be increased when used in combination with Isradipine.
Amoxicillin Amoxicillin Isradipine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Nafcillin Injection Nafcillin Injection The therapeutic efficacy of Isradipine can be decreased when used in combination with Nafcillin.
Oxacillin Injection Oxacillin Injection Isradipine may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may increase the hypotensive activities of Isradipine.
Pentamidine Injection Pentamidine Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Isradipine which could result in a higher serum level.
Labetalol Labetalol The risk or severity of bradycardia can be increased when Labetalol is combined with Isradipine.
Auranofin Auranofin Isradipine may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection The risk or severity of QTc prolongation can be increased when Isradipine is combined with Leuprolide.
Gemfibrozil Gemfibrozil Isradipine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz Isradipine may decrease the antihypertensive activities of Guanabenz.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Isradipine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Isradipine which could result in a higher serum level.
Ketoprofen Ketoprofen The therapeutic efficacy of Isradipine can be decreased when used in combination with Ketoprofen.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Isradipine which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Isradipine.
Enalapril Enalapril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Enalapril.
Flurbiprofen Flurbiprofen The therapeutic efficacy of Isradipine can be decreased when used in combination with Flurbiprofen.
Amiodarone Amiodarone The risk or severity of adverse effects can be increased when Isradipine is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Isradipine may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Isradipine which could result in a higher serum level.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Isradipine.
Ciprofloxacin Ciprofloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ciprofloxacin.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Diclofenac Diclofenac The therapeutic efficacy of Isradipine can be decreased when used in combination with Diclofenac.
Fluoxetine Fluoxetine The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Isradipine.
Nimodipine Nimodipine Isradipine may increase the arrhythmogenic activities of Nimodipine.
Clozapine Clozapine The risk or severity of hypotension can be increased when Clozapine is combined with Isradipine.
Estazolam Estazolam Isradipine may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin Ofloxacin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Ofloxacin.
Didanosine Didanosine Isradipine may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Isradipine may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Clarithromycin Clarithromycin Isradipine may decrease the excretion rate of Clarithromycin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Benazepril.
Etodolac Etodolac The therapeutic efficacy of Isradipine can be decreased when used in combination with Etodolac.
Felodipine Felodipine Isradipine may increase the arrhythmogenic activities of Felodipine.
Fosinopril Fosinopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Fosinopril.
Nabumetone Nabumetone The therapeutic efficacy of Isradipine can be decreased when used in combination with Nabumetone.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Quinapril.
Ramipril Ramipril The risk or severity of hyperkalemia can be increased when Ramipril is combined with Isradipine.
Simvastatin Simvastatin Isradipine may decrease the excretion rate of Simvastatin which could result in a higher serum level.
Amlodipine Amlodipine Isradipine may increase the arrhythmogenic activities of Amlodipine.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be decreased when combined with Isradipine.
Itraconazole Itraconazole The risk or severity of QTc prolongation can be increased when Isradipine is combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Lisinopril.
Oxaprozin Oxaprozin The therapeutic efficacy of Isradipine can be decreased when used in combination with Oxaprozin.
Sotalol Sotalol The risk or severity of bradycardia can be increased when Isradipine is combined with Sotalol.
Bisoprolol Bisoprolol The therapeutic efficacy of Isradipine can be increased when used in combination with Bisoprolol.
Doxazosin Doxazosin The risk or severity of hypotension can be increased when Doxazosin is combined with Isradipine.
Terazosin Terazosin The risk or severity of hypotension can be increased when Terazosin is combined with Isradipine.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Isradipine.
Venlafaxine Venlafaxine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Venlafaxine.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Isradipine.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Isradipine which could result in a higher serum level.
Nefazodone Nefazodone Nefazodone may decrease the excretion rate of Isradipine which could result in a higher serum level.
Lamotrigine Lamotrigine Isradipine may increase the arrhythmogenic activities of Lamotrigine.
Losartan Losartan Isradipine may increase the arrhythmogenic activities of Losartan.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Isradipine.
Vinorelbine Injection Vinorelbine Injection The metabolism of Vinorelbine can be decreased when combined with Isradipine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Isradipine which could result in a higher serum level.
Moexipril Moexipril The risk or severity of QTc prolongation can be increased when Isradipine is combined with Moexipril.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be decreased when combined with Isradipine.
Nicardipine Nicardipine Isradipine may increase the arrhythmogenic activities of Nicardipine.
Bupropion Bupropion Isradipine may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Isradipine can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The risk or severity of QTc prolongation can be increased when Isradipine is combined with Saquinavir.
Metformin Metformin The risk or severity of hypoglycemia can be increased when Isradipine is combined with Metformin.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Isradipine is combined with Dalteparin.
Nisoldipine Nisoldipine Isradipine may increase the arrhythmogenic activities of Nisoldipine.
Lamivudine Lamivudine Isradipine may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Amifostine Injection Amifostine Injection Isradipine may increase the hypotensive activities of Amifostine.
Acarbose Acarbose The risk or severity of hypoglycemia can be increased when Isradipine is combined with Acarbose.
Glimepiride Glimepiride Glimepiride may increase the arrhythmogenic activities of Isradipine.
Gemcitabine Injection Gemcitabine Injection Isradipine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Indinavir Indinavir Indinavir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Ritonavir Ritonavir The serum concentration of Ritonavir can be increased when it is combined with Isradipine.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be decreased when combined with Isradipine.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Isradipine may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Isradipine can be decreased when combined with Clomipramine.
Zafirlukast Zafirlukast The metabolism of Isradipine can be decreased when combined with Zafirlukast.
Fosfomycin Fosfomycin Isradipine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Isradipine.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Isradipine is combined with Trandolapril.
Topiramate Topiramate Isradipine may decrease the excretion rate of Topiramate which could result in a higher serum level.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Isradipine.
Insulin Lispro Injection Insulin Lispro Injection The risk or severity of hypoglycemia can be increased when Isradipine is combined with Insulin lispro.
Pramipexole Pramipexole Isradipine may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Donepezil Donepezil Isradipine may increase the bradycardic activities of Donepezil.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Azithromycin Azithromycin The risk or severity of QTc prolongation can be increased when Isradipine is combined with Azithromycin.
Loratadine Loratadine Isradipine may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol The risk or severity of bradycardia can be increased when Carvedilol is combined with Isradipine.
Nilutamide Nilutamide Isradipine may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Isradipine may decrease the excretion rate of Flutamide which could result in a higher serum level.
Selegiline Selegiline Selegiline may increase the hypotensive activities of Isradipine.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be decreased when combined with Isradipine.
Propafenone Propafenone The risk or severity of bradycardia can be increased when Isradipine is combined with Propafenone.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Isradipine is combined with Irbesartan.
Tamsulosin Tamsulosin The risk or severity of hypotension can be increased when Isradipine is combined with Tamsulosin.
Ropinirole Ropinirole The risk or severity of adverse effects can be increased when Ropinirole is combined with Isradipine.
Finasteride Finasteride Finasteride may decrease the antihypertensive activities of Isradipine.
Quetiapine Quetiapine Isradipine may increase the hypotensive activities of Quetiapine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Isradipine which could result in a higher serum level.
Cetirizine Cetirizine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Cetirizine.
Tolcapone Tolcapone Isradipine may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram The risk or severity of QTc prolongation can be increased when Isradipine is combined with Citalopram.
Capecitabine Capecitabine Isradipine may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz The serum concentration of Isradipine can be decreased when it is combined with Efavirenz.
Abacavir Abacavir Isradipine may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil Sildenafil may increase the antihypertensive activities of Isradipine.
Pioglitazone Pioglitazone The risk or severity of hypoglycemia can be increased when Isradipine is combined with Pioglitazone.
Celecoxib Celecoxib The therapeutic efficacy of Isradipine can be decreased when used in combination with Celecoxib.
Rosiglitazone Rosiglitazone The risk or severity of hypoglycemia can be increased when Isradipine is combined with Rosiglitazone.
Tolterodine Tolterodine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Tolterodine.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Isradipine.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Isradipine which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Isradipine which could result in a higher serum level.
Nateglinide Nateglinide The risk or severity of hypoglycemia can be increased when Isradipine is combined with Nateglinide.
Galantamine Galantamine The risk or severity of QTc prolongation can be increased when Isradipine is combined with Galantamine.
Rabeprazole Rabeprazole Isradipine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists